These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 19930)

  • 1. Effects of beta-adrenoceptor blocking agents on haemodynamic parameters.
    Hansson L
    Acta Med Scand Suppl; 1977; 606():49-54. PubMed ID: 19930
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-adrenergic receptor blocking drugs in hypertension.
    Simpson FO
    Drugs; 1974; 7(1):85-105. PubMed ID: 4152167
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of beta-adrenergic blocking agents on the blood pressure, plasma renin activity and hemodynamics of hypertensive patients.
    Matsunaga M; Hara A; Ogino K; Motohara S; Saito M
    Jpn Heart J; 1977 Jan; 18(1):24-30. PubMed ID: 15142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Large arteries in hypertension: heterogeneous haemodynamic response to beta-adrenoceptor antagonists with and without intrinsic sympathomimetic activity.
    Simon AC; Levenson J; Pithois-Merli I
    Br J Clin Pharmacol; 1987; 24 Suppl 1(Suppl 1):45S-49S. PubMed ID: 2894224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in haemodynamic response to beta-blocking drugs between stable coronary artery disease and acute myocardial infarction.
    Silke B; Frais MA; Verma SP; Reynolds G; Taylor SH
    Eur J Clin Pharmacol; 1986; 29(6):659-65. PubMed ID: 2872054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evaluation of myocardial relaxation in the treatment of arterial hypertension: vasodilators and beta blockers].
    Gimeno JV; Martín G; Cosín J
    Rev Esp Cardiol; 1985; 38(5):342-7. PubMed ID: 2867585
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combination of betablocking-vasodilator and diuretic agents in the treatment of arterial hypertension. Changes in Hemodynamics and plasma-renin levels].
    Fernández-Andrade C; Herrera Carranza M; Villalobos Galán E; Mateos Aguilar J; Quereda C; Navarro R; Martinez Martin A; Mendoza Llera M
    Rev Clin Esp; 1978 Mar; 148(5):491-6. PubMed ID: 27844
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemodynamic effects of beta-adrenergic blockade with pindolol, oxprenolol, propranolol and bufetolol hydrochloride in essential hypertension.
    Tsukiyama H; Otsuka K; Miyamoto K; Hashimoto M; Yasutake S
    Jpn Circ J; 1976 Jun; 40(6):655-64. PubMed ID: 7688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of propranolol in hypertension: a review.
    Hansson L
    Postgrad Med J; 1976; 52 Suppl 4():77-80. PubMed ID: 9634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical pharmacology of pindolol.
    Aellig WH
    Am Heart J; 1982 Aug; 104(2 Pt 2):346-56. PubMed ID: 6125094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilation in treatment of hypertension.
    Chidsey CA
    N Engl J Med; 1970 May; 282(19):1102-3. PubMed ID: 4392414
    [No Abstract]   [Full Text] [Related]  

  • 12. [Phrmacodynamic principles underlying the specific therapy of coronary vascular disease].
    Kraupp O
    Wien Klin Wochenschr; 1973 Feb; 85(8):115-22. PubMed ID: 4144095
    [No Abstract]   [Full Text] [Related]  

  • 13. Propranolol and beta-adrenergic receptor blocking drugs in the treatment of hypertension.
    Prichard BN
    Br J Clin Pharmacol; 1982 Jan; 13(1):51-60. PubMed ID: 6121573
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-adrenoceptor blockade and vasodilatation in essential hypertension. Hemodynamic studies at rest and during exposure to stress.
    Eggertsen R
    Acta Med Scand Suppl; 1984; 689():1-46. PubMed ID: 6151343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blocking agents in the treatment of hypertension.
    Stumpe KO; Kolloch RE
    Compr Ther; 1977 May; 3(5):55-65. PubMed ID: 16724
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prospects of beta-blocking treatment in arterial hypertension].
    Cosma M
    Rev Med Chir Soc Med Nat Iasi; 1979; 83(4):573-8. PubMed ID: 45049
    [No Abstract]   [Full Text] [Related]  

  • 17. Bopindolol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.
    Harron DW; Goa KL; Langtry HD
    Drugs; 1991 Jan; 41(1):130-49. PubMed ID: 1706984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. beta-Adrenoceptor antagonists: new drugs and new indications.
    Koch-Weser J; Frishman WH
    N Engl J Med; 1981 Aug; 305(9):500-6. PubMed ID: 6114433
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term haemodynamic effects of a 4-week regimen of nipradilol, a new beta-blocker with nitrovasodilating properties, in patients with portal hypertension due to cirrhosis. A comparative study with propranolol.
    Aramaki T; Sekiyama T; Katsuta Y; Kurokawa H; Komeichi H; Tsutsui H; Terada H; Ohsuga M; Satomura K; Okumura H
    J Hepatol; 1992 May; 15(1-2):48-53. PubMed ID: 1354676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative review of beta-blocking agents.
    Jackson EA; Sullman SA
    Conn Med; 1984 Apr; 48(4):213-5. PubMed ID: 6143648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.